BIO tech 2012
BIO tech 2012
A Partnering Event will take place in Japan: a gold mine of bio/pharma-related seeds!
Japanese academia: a gold mine of bio/pharma-related seeds
For BIO tech 2012, a large number of pharmaceutical companies have pledged their support as Sponsors – from mega pharmaceuticals like MSD, Roche, sanofi and NOVARTIS to Japanese major pharmaceutical companies as Takeda Pharmaceutical, Astellas Pharma, etc. They are also actively welcoming appointments for on-site meetings at BIO tech 2012, seeking to discover seeds and find partners among the Japanese academia.
What is Academic Forum?
Renewed as a platform for “business-academia collaboration”, it attracts a large number of presenters from universities and research institutes, who will disclose their latest research achievements here.
Presentation Title / Presenters (excerpt from 300* sessions)
- Anti-inflammatory protein Thioredoxin Hybrid Translational Research
KYOTO UNIVERSITY, Institute for Virus Research, Prof.Em / Ewha Womans Univ, WCU_Prof. Dr. Junji Yodoi
- Semiconductor-based biosensing platform for clinical diagnosis and drug discovery
The University of Tokyo, Department of Materials Engineering, Graduate School of Engineering, Associate Professor, Dr. Toshiya Sakata
- Application of Neoglycolipids for Cancer and Autoimmune Diseases by Regulating Immune System
RIKEN, Research Center for Allergy and Immunology Senior Research Scientist, Dr. Hiroshi Watarai
Pharma Company Sponsors below and many more will join partnering at BIO tech 2012.
AJINOMOTO PHARMACEUTICALS, Astellas Pharma, AstraZeneca, Chugai Pharmaceutical, DAIICHI SANKYO, Dainippon Sumitomo Pharma, Eli Lilly Japan, F. Hoffmann-La Roche, JANSSEN PHARMACEUTICAL, KAKEN PHARMACEUTICAL, KYORIN Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, NIPPON SHINYAKU, NOVARTIS PHARMA, sanofi-aventis, Takeda Pharmaceutical (as of March 18th, in alphabetical order)
Of course, above sponsors are not the only ones who are eager to find seeds/partners in Japan. Other pharmaceutical companies and investors from over the world will visit BIO tech 2012 seeking for business opportunities (28,000 visitors expected). Considering BIO tech 2012 as the most important platform to explore the Japanese & Asian market, many companies will join Partnering here. By staggering show dates with respect to other bio events in Europe and the US, the 2012 show is expected to gather an increased number of overseas attendees.
About BIO tech 2012 (April 25 – 27, Tokyo Big Sight)
Asia’s largest bio event consisting of Partnering, Conference and Exhibition.
Foto: © BIO tech
Ausgabe L&M 1 / 2012
Das komplette Heft zum kostenlosen Download finden Sie hier: zum Download
Weitere Artikel online lesen